Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide

<p>Abstract</p> <p>Background</p> <p>Chemokines are emerging as important mediators of CNS inflammation capable of activating leukocyte integrins and directing the migration of leukocyte subsets to sites of antigenic challenge. In this study we investigated the expressi...

Full description

Bibliographic Details
Main Authors: Dorovini-Zis Katerina, Chui Ray
Format: Article
Language:English
Published: BMC 2010-01-01
Series:Journal of Neuroinflammation
Online Access:http://www.jneuroinflammation.com/content/7/1/1
id doaj-5bfb022f6206409d967dc33ce501b100
record_format Article
spelling doaj-5bfb022f6206409d967dc33ce501b1002020-11-25T00:37:56ZengBMCJournal of Neuroinflammation1742-20942010-01-0171110.1186/1742-2094-7-1Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharideDorovini-Zis KaterinaChui Ray<p>Abstract</p> <p>Background</p> <p>Chemokines are emerging as important mediators of CNS inflammation capable of activating leukocyte integrins and directing the migration of leukocyte subsets to sites of antigenic challenge. In this study we investigated the expression, release and binding of CCL2 (MCP-1) and CCL3 (MIP-1α) in an in vitro model of the human blood-brain barrier.</p> <p>Methods</p> <p>The kinetics of expression and cytokine upregulation and release of the β-chemokines CCL2 and CCL3 were studied by immunocytochemistry and enzyme-linked immunosorbent assay in primary cultures of human brain microvessel endothelial cells (HBMEC). In addition, the differential binding of these chemokines to the basal and apical endothelial cell surfaces was assessed by immunoelectron microscopy.</p> <p>Results</p> <p>Untreated HBMEC synthesize and release low levels of CCL2. CCL3 is minimally expressed, but not released by resting HBMEC. Treatment with TNF-α, IL-1β, LPS and a combination of TNF-α and IFN-γ, but not IFN-γ alone, significantly upregulated the expression and release of both chemokines in a time-dependent manner. The released CCL2 and CCL3 bound to the apical and basal endothelial surfaces, respectively. This distribution was reversed in cytokine-activated HBMEC resulting in a predominantly basal localization of CCL2 and apical distribution of CCL3.</p> <p>Conclusions</p> <p>Since cerebral endothelial cells are the first resident CNS cells to contact circulating leukocytes, expression, release and presentation of CCL2 and CCL3 on cerebral endothelium suggests an important role for these chemokines in regulating the trafficking of inflammatory cells across the BBB in CNS inflammation.</p> http://www.jneuroinflammation.com/content/7/1/1
collection DOAJ
language English
format Article
sources DOAJ
author Dorovini-Zis Katerina
Chui Ray
spellingShingle Dorovini-Zis Katerina
Chui Ray
Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
Journal of Neuroinflammation
author_facet Dorovini-Zis Katerina
Chui Ray
author_sort Dorovini-Zis Katerina
title Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
title_short Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
title_full Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
title_fullStr Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
title_full_unstemmed Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
title_sort regulation of ccl2 and ccl3 expression in human brain endothelial cells by cytokines and lipopolysaccharide
publisher BMC
series Journal of Neuroinflammation
issn 1742-2094
publishDate 2010-01-01
description <p>Abstract</p> <p>Background</p> <p>Chemokines are emerging as important mediators of CNS inflammation capable of activating leukocyte integrins and directing the migration of leukocyte subsets to sites of antigenic challenge. In this study we investigated the expression, release and binding of CCL2 (MCP-1) and CCL3 (MIP-1α) in an in vitro model of the human blood-brain barrier.</p> <p>Methods</p> <p>The kinetics of expression and cytokine upregulation and release of the β-chemokines CCL2 and CCL3 were studied by immunocytochemistry and enzyme-linked immunosorbent assay in primary cultures of human brain microvessel endothelial cells (HBMEC). In addition, the differential binding of these chemokines to the basal and apical endothelial cell surfaces was assessed by immunoelectron microscopy.</p> <p>Results</p> <p>Untreated HBMEC synthesize and release low levels of CCL2. CCL3 is minimally expressed, but not released by resting HBMEC. Treatment with TNF-α, IL-1β, LPS and a combination of TNF-α and IFN-γ, but not IFN-γ alone, significantly upregulated the expression and release of both chemokines in a time-dependent manner. The released CCL2 and CCL3 bound to the apical and basal endothelial surfaces, respectively. This distribution was reversed in cytokine-activated HBMEC resulting in a predominantly basal localization of CCL2 and apical distribution of CCL3.</p> <p>Conclusions</p> <p>Since cerebral endothelial cells are the first resident CNS cells to contact circulating leukocytes, expression, release and presentation of CCL2 and CCL3 on cerebral endothelium suggests an important role for these chemokines in regulating the trafficking of inflammatory cells across the BBB in CNS inflammation.</p>
url http://www.jneuroinflammation.com/content/7/1/1
work_keys_str_mv AT doroviniziskaterina regulationofccl2andccl3expressioninhumanbrainendothelialcellsbycytokinesandlipopolysaccharide
AT chuiray regulationofccl2andccl3expressioninhumanbrainendothelialcellsbycytokinesandlipopolysaccharide
_version_ 1725298891530698752